Revenue · 2015–2025

AstraZeneca revenue

$58.7B+8.6% · FY2025

AstraZeneca (AZN) reported $58.7B in revenue for fiscal 2025, +8.6% year on year.

$24.7B2015$23.0B2016$22.5B2017$22.1B2018$24.4B2019$26.6B2020$37.4B2021$44.4B2022$45.8B2023$54.1B2024$58.7B2025
AstraZeneca — Revenue, 2015–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$58.7B+8.6%Open →
FY20242024-12-31$54.1B+18.0%Open →
FY20232023-12-31$45.8B+3.3%Open →
FY20222022-12-31$44.4B+18.5%Open →
FY20212021-12-31$37.4B+40.6%Open →
FY20202020-12-31$26.6B+9.2%Open →
FY20192019-12-31$24.4B+10.4%Open →
FY20182018-12-31$22.1B−1.7%Open →
FY20172017-12-31$22.5B−2.3%Open →
FY20162016-12-31$23.0B−6.9%Open →
FY20152015-12-31$24.7B—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +9.0%

Figures are reported under IFRS, in US dollars.

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=AstraZeneca revenue |url=https://companiesranked.com/en/company/astrazeneca/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). AstraZeneca revenue. CompaniesRanked. https://companiesranked.com/en/company/astrazeneca/revenue

BibTeX

@misc{companiesranked-en-company-astrazeneca-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{AstraZeneca revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/astrazeneca/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001104659-26-019130 · February 24, 2026

{{cite web |title=AstraZeneca revenue — 20-F (0001104659-26-019130) |url=https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/azn-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← AstraZeneca overview